Kriya Therapeutics

Gene Therapy. Redefined.

Research Triangle Park, United States · Founded 2019 · $655.0M raised

Founded
2019
Business Model
B2B
Total Funding
$655.0M
Last Round
$320.0M Series DSep 2025
Rounds
4

About

Kriya Therapeutics is a biopharmaceutical company developing life-changing gene therapies for widespread chronic diseases including ophthalmology, metabolic, and neurological conditions. Founded in 2019, Kriya's mission is to make gene therapies accessible to millions by integrating product design, R&D, and manufacturing under one roof.

Summary

Kriya Therapeutics is a Biotech company based in Research Triangle Park, United States, founded in 2019. It has raised $655.0M in total across 4 rounds, most recently a $320.0M Series D round in Sep 2025. Investors include Patient Square Capital, Premji Invest and Peter Thiel.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DSep 2025
$320.0M

Sign up to see all 4 rounds

Series C through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kriya Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/kriya-therapeutics"><img src="https://indexed.vc/api/badge/company/kriya-therapeutics" alt="Kriya Therapeutics on Indexed.vc" width="260" height="76" /></a>